Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912, USA; Immunotherapy Center, Medical College of Georgia, Augusta, GA 30912, USA.
Immunity. 2010 Dec 14;33(6):942-54. doi: 10.1016/j.immuni.2010.11.022. Epub 2010 Dec 9.
Foxp3(+) regulatory T (Treg) cells can undergo reprogramming into a phenotype expressing proinflammatory cytokines. However, the biologic significance of this conversion remains unclear. We show that large numbers of Treg cells undergo rapid reprogramming into activated T helper cells after vaccination with antigen plus Toll-like receptor 9 (TLR-9) ligand. Helper activity from converted Treg cells proved essential during initial priming of CD8(+) T cells to a new cross-presented antigen. Help from Treg cells was dependent on CD40L, and (unlike help from conventional non-Treg CD4(+) cells) did not require preactivation or prior exposure to antigen. In hosts with established tumors, Treg cell reprogramming was suppressed by tumor-induced indoleamine 2,3-dioxygenase (IDO) and vaccination failed because of lack of help. Treg cell reprogramming, vaccine efficacy, and antitumor CD8(+) T cell responses were restored by pharmacologic inhibition of IDO. Reprogrammed Treg cells can thus participate as previously unrecognized drivers of certain early CD8(+) T cell responses.
Foxp3(+) 调节性 T (Treg) 细胞可以重新编程为表达促炎细胞因子的表型。然而,这种转化的生物学意义尚不清楚。我们发现,在接种抗原加 Toll 样受体 9 (TLR-9) 配体后,大量 Treg 细胞迅速重新编程为活化的辅助性 T 细胞。在新的交叉呈递抗原的 CD8(+) T 细胞的初始启动过程中,来自转化的 Treg 细胞的辅助作用至关重要。Treg 细胞的辅助作用依赖于 CD40L,并且(与传统的非 Treg CD4(+) 细胞的辅助作用不同)不需要预先激活或预先暴露于抗原。在已建立肿瘤的宿主中,肿瘤诱导的吲哚胺 2,3-双加氧酶 (IDO) 抑制了 Treg 细胞的重新编程,并且由于缺乏辅助作用,疫苗接种失败。通过抑制 IDO,可恢复 Treg 细胞的重新编程、疫苗效力和抗肿瘤 CD8(+) T 细胞反应。因此,重新编程的 Treg 细胞可以作为先前未被识别的某些早期 CD8(+) T 细胞反应的驱动因素之一。